DAE HWA Pharmaceutical Co., Ltd.

A067080

KR7067080002

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 03:30:00 14/05/2024 am IST			5-day change	1st Jan Change
10,210 ^KRW	+1.39%		-5.20%	+8.85%

2022	DAE HWA Pharmaceutical Co., Ltd.(KOSDAQ:A067080) dropped from S&P Global BMI Index	CI
2019	Mediforum Co.,Ltd. acquired 13.9% stake in C-TRI Co., Ltd. from DAE HWA Pharmaceutical Co., Ltd. and Wanjoo Kim for KRW 20.2 billion.	CI

DAE HWA Pharmaceutical Co., Ltd.(KOSDAQ:A067080) added to MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index

December 01, 2015 at 10:30 am IST

Latest news about DAE HWA Pharmaceutical Co., Ltd.

DAE HWA Pharmaceutical Co., Ltd.(KOSDAQ:A067080) dropped from S&P Global BMI Index	19/22/19	CI
Mediforum Co.,Ltd. acquired 13.9% stake in C-TRI Co., Ltd. from DAE HWA Pharmaceutical Co., Ltd. and Wanjoo Kim for KRW 20.2 billion.	05/19/05	CI
DAE HWA Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 6, 2019, has expired.	06/19/06	CI
DAE HWA Pharmaceutical Co., Ltd. announces an Equity Buyback for 360,000 shares.	06/19/06	CI
DAE HWA Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	06/19/06	CI
DAE HWA Pharmaceutical Co., Ltd. announced that it has received KRW 20 billion in funding	29/19/29	CI
DAE HWA Pharmaceutical Co., Ltd. announced that it expects to receive KRW 20 billion in funding	28/19/28	CI
Shanghai Haihe Biopharma Co., Ltd. announced that it has received $146.6 million in funding from a group of investors	11/19/11	CI
DAE HWA Pharmaceutical Co., Ltd.(KOSDAQ:A067080) added to MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index	01/15/01	CI
DAE HWA Pharmaceutical Co., Ltd.(KOSDAQ:A067080) added to S&P Global BMI Index	21/15/21	CI
DAE HWA Pharmaceutical Co., Ltd.(KOSDAQ:A067080) added to Russell Global Index	29/15/29	CI
DAE HWA Pharmaceutical Co., Ltd. cancelled the acquisition of REDOXBIL CO.,LTD.	31/14/31	CI
DAE HWA Pharmaceutical Co., Ltd. agreed to acquire REDOXBIL CO.,LTD. for KRW 1.1 billion.	31/13/31	CI
Dae Hwa Pharmaceutical Co., Ltd Proposes Dividend	28/13/28	CI

Chart DAE HWA Pharmaceutical Co., Ltd.

Duration

Period

More charts

DAE HWA PHARM CO.,LTD. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include skeletal muscle relaxants, gastro-intestinal drugs, corticosteroids, antihistamines, cardiovascular drugs, drugs for liver diseases, vitamins, tonics, antibiotics, injections, topical drugs, anti-inflammatory enzymes, analgesics, antipyretics, plaster, cough suppressants, expectorants and mucolytics, drugs for hemorrhoid disease and other prescription drugs, as well as over-the-counter (OTC) drugs. The Company distributes its products within domestic market and to overseas markets. On August 22, 2013, it acquired a certain shares of a Korea-based company, which is mainly engaged in the manufacture of medicine raw materials and development of medical devices. After the transaction, the Company held a 100% stake of the Korea-based company.

Sector

Pharmaceuticals

Calendar

09/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
DAE HWA PHARMACEUTICAL CO., LTD.	+8.85%	13Cr
MERCK KGAA	+9.85%	7.45TCr
KYOWA KIRIN CO. LTD.	+11.35%	918Cr
SK BIOPHARMACEUTICALS CO., LTD.	-12.85%	502.18Cr
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+60.16%	503.01Cr
YUHAN CORPORATION	+1.60%	382.03Cr
BETTA PHARMACEUTICALS CO., LTD.	-19.20%	240.99Cr
INDIVIOR PLC	+18.65%	239.16Cr
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+24.62%	226.23Cr
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-27.46%	227.4Cr

Specialty & Advanced Pharmaceuticals